NeuroLog

First 'atlas' of key brain genes could speed research on cancer, neurological diseases

Researchers at Dana-Farber Cancer Institutehave compiled the first atlas showing the locations of crucial generegulators, or switches that determine how different parts of the braindevelop ?and, in some cases, develop abnormally or malfunction.The scientists say the map will accelerate research on brain tumors andneurological diseases that result from mutations in these switch genes?called...

Antibiotic might fight HIV-induced neurological problems

By studying animals, Johns Hopkins researchers have discovered that the antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system, problems that can develop even though antiretroviral therapy controls the virus elsewhere in the body. Five monkeys infected with simian immunodeficiency virus (SIV), a very close relative of HIV, and treated wi...

Use of Insecticides Linked to Lasting Neurological Problems for Farmers

New research shows that farmers who used agricultural insecticides experienced increased neurological symptoms, even when they were no longer using the products. Data from 18,782 North Carolina and Iowa farmers linked use of insecticides, including organophosphates and organochlorines, to reports of reoccurring headaches, fatigue, insomnia, dizziness, nausea, hand tremors, numbness and other neur...

UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders

Experts in bioengineering, imaging, molecular genetics, immunology, ethics, hematology/oncology and cellular biology to collaborate on Proposition 71 research Drawing together experts from fields as diverse as engineering to molecular biology, UCLA officials announced March 16 the formation of the Institute for Stem Cell Biology and Medicine to conduct embryonic and adult stem cell resear...

Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease

Investigators report safety findings and statistically significant improvements in clinical measures of movement, PET Scans at 19th Annual Symposia on the Etiology, Pathogenesis and Treatment of Parkinson's Disease and Other Movement DisordersNeurologix's Phase I trial showed positive interim results in patients with Parkinson's disease. One year following treatment, patients exhibited a statist...

Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice

In an important discovery, scientists have demonstrated that the progression of a type of genetic brain disease is slowed and symptoms are improved in mice that received cell transplants. , may have implications for developing new therapies for metachromatic leukodystrophy, or MLD, a fatal, relatively rare...

Mechanism identified for promising neurological drug

Researchers at the San Francisco VA Medical Center have identified the mechanism by which minocycline, a medication currently being studied for the treatment of neurodegenerative diseases including Parkinson's disease and Huntington's disease, protects brain and nerve cells from damage. In the study, conducted in cell culture, the team determined that the drug blocks the action of poly(ADP...